These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 4397967
1. [Degradation products of fibrinogen in connective tissue disorders: probable relation to the presence of microangiopathies]. Alarcon-Segovia D, Fishbein E, Zavala Mejía JL. Rev Invest Clin; 1971; 23(1):43-7. PubMed ID: 4397967 [No Abstract] [Full Text] [Related]
2. [Autoantibodies in collagen diseases]. Meyer O. Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515 [No Abstract] [Full Text] [Related]
3. The immunology of rheumatoid diseases. Koffler D. Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382 [No Abstract] [Full Text] [Related]
5. [Use of immunodiffusion (RID) for quantiative evaluation of immunoglobulins in the rheumatological field]. Biddau A, Bartoletti L, Doni A. Reumatismo; 1968 May; 20(5):545-9. PubMed ID: 4186692 [No Abstract] [Full Text] [Related]
6. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases. Webb J, Whaley K, Lee P. Scott Med J; 1974 Jul; 19(4):171-5. PubMed ID: 4209789 [No Abstract] [Full Text] [Related]
7. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus]. Peltier AP. Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383 [No Abstract] [Full Text] [Related]
8. Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs. Turner-Warwick M. Proc R Soc Med; 1974 Jun; 67(6 Pt 2):541-7. PubMed ID: 4152998 [No Abstract] [Full Text] [Related]
9. [The lung in connectivitis]. Schettini A, Iones F, D'Andrea A, Pucino A, Vatrella A, Marsico SA. Arch Monaldi; 1984 Jun; 39(1-2):3-26. PubMed ID: 6398036 [No Abstract] [Full Text] [Related]
14. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases]. Loskutova TT, Koreshkov GG, Nasonov EL, Zakharchenko VN, Larionov SM. Ter Arkh; 1989 Oct; 61(5):51-5. PubMed ID: 2781490 [No Abstract] [Full Text] [Related]
15. [Clinical definition of the collagen diseases]. Bäumer A. Z Rheumaforsch; 1968 Apr; 27(3):85-7. PubMed ID: 4176736 [No Abstract] [Full Text] [Related]
16. [Inflammatory rheumatism within the framework of autoimmune diseases]. Van Slype J. J Belge Rhumatol Med Phys; 1967 Apr; 22(4):204-7. PubMed ID: 4185872 [No Abstract] [Full Text] [Related]
17. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases]. Wysocka K, Kiczak J. Reumatologia; 1982 Apr; 20(1-2):15-21. PubMed ID: 7163659 [No Abstract] [Full Text] [Related]
18. [Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases]. Fabregas-Canales D, Meyer O, Haim T, Kuntz D. Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):45-50. PubMed ID: 2471252 [No Abstract] [Full Text] [Related]
19. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies. Levo Y, Lotan C. Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327 [No Abstract] [Full Text] [Related]
20. The immune secretory system and rheumatoid diseases. Luft S. Mater Med Pol; 1983 Feb; 15(1-2):3-8. PubMed ID: 6608643 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]